Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L5RA
|
|||
Drug Name |
PMID25468267-Compound-47
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C28H31N3O6
|
|||
Canonical SMILES |
COC(=O)C=CC(=O)N(CCCCNCC1=CC=C(C=C1)COC(=O)NC2=CC=CC3=CC=CC=C32)O
|
|||
InChI |
1S/C28H31N3O6/c1-36-27(33)16-15-26(32)31(35)18-5-4-17-29-19-21-11-13-22(14-12-21)20-37-28(34)30-25-10-6-8-23-7-2-3-9-24(23)25/h2-3,6-16,29,35H,4-5,17-20H2,1H3,(H,30,34)/b16-15+
|
|||
InChIKey |
MUJOCHRZXRZONW-FOCLMDBBSA-N
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:95078
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Lysine-specific demethylase 4C (KDM4C) | Target Info | Inhibitor | [1] |
Target's Patent Info | Lysine-specific demethylase 4C (KDM4C) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):135-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.